Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Repros Therapeutics
Continue ReadingTag: investment
Despite Facing Steep Drops in Coal Shipments Railroads Posting Strong Earnings
Five Star Equities Provides Stock Research on CSX and Kansas City Southern
Continue Reading
Biotech Industry Expected to Experience More Merger & Acquisition Activity in 2013
Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and Vical
Continue Reading
Recoveries in U.S. Housing and Automotive Markets Help Offset Drops in Coal Demand for Railroad Companies
Five Star Equities Provides Stock Research on Norfolk Southern and Union Pacific
Continue Reading
Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements
Five Star Equities Provides Stock Research on Sunesis Pharmaceuticals and XOMA
Continue Reading
Biotech M&A Activity to Rise in 2013 as Pharma Companies Look to Replace Lost Revenues
Five Star Equities Provides Stock Research on AVEO Pharmaceuticals and Repros Therapeutics
Continue Reading
Utilities Diversifying Electricity Generating Portfolios to Protect Themselves From Future Uncertainties
Five Star Equities Provides Stock Research on Duke Energy and The Southern Company
Continue Reading
Despite Cheap Prices Utilities Reluctant to Rely Heavily on Natural Gas
Five Star Equities Provides Stock Research on American Electric Power and Exelon
Continue Reading
Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand
Five Star Equities Provides Stock Research on Dynavax Technologies and Synta Pharmaceuticals
Continue Reading
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
Five Star Equities Provides Stock Research on Astex Pharmaceuticals and BioTime
Continue Reading